ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
0.7500
+0.0286 (3.96%)
At close: May 12, 2025, 4:00 PM
0.7590
+0.0090 (1.20%)
After-hours: May 12, 2025, 5:55 PM EDT
ProKidney Market Cap
ProKidney has a market cap or net worth of $219.52 million as of May 12, 2025. Its market cap has increased by 31.46% in one year.
Market Cap
219.52M
Enterprise Value
-135.53M
1-Year Change
31.46%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $50.55M to $219.52M, an increase of 334.27%. That is a compound annual growth rate of 46.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 93.45M | -56.79% |
| Dec 31, 2024 | 216.27M | 80.97% |
| Dec 29, 2023 | 119.50M | -71.69% |
| Dec 30, 2022 | 422.17M | 33.72% |
| Dec 31, 2021 | 315.71M | 524.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |